ORIC Pharmaceuticals, Inc. (ORIC) Tops Q3 EPS by 7c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q3 EPS of ($0.33), $0.07 better than the analyst estimate of ($0.40).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• Synthesis Energy Systems (SES) Reports In-Line Q2 EPS, Misses on Revenue; Offers FY26 Revenue Guidance
• BofA says hedge funds had biggest buying week since 2008 last week
• Super Micro Computer (SMCI) Tops Q4 EPS by 99c; offers guidance